Click here to get full coverage on Q1 Earnings Estimate for CNTB Issued By HC Wainwright - MarketBeat

Q1 Earnings Estimate for CNTB Issued By HC Wainwright  MarketBeat

Q1 Earnings Estimate for CNTB Issued By HC Wainwright - MarketBeat

Click here to get full coverage on If You Invested $1,000 in Connect Biopharma Holdings Ltd (CNTB) - Stock Titan

If You Invested $1,000 in Connect Biopharma Holdings Ltd (CNTB)  Stock Titan

If You Invested $1,000 in Connect Biopharma Holdings Ltd (CNTB) - Stock Titan

Click here to get full coverage on H.C. Wainwright Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $7 - 富途牛牛

H.C. Wainwright Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $7  富途牛牛

H.C. Wainwright Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $7 - 富途牛牛

Click here to get full coverage on ETFs Investing in Connect Biopharma Holdings Ltd. Stocks - TradingView

ETFs Investing in Connect Biopharma Holdings Ltd. Stocks  TradingView

ETFs Investing in Connect Biopharma Holdings Ltd. Stocks - TradingView

Click here to get full coverage on Connect Biopharma Holdings Limited's (NASDAQ:CNTB) largest shareholders are private equity firms with 39% ownership, individual investors own 22% - Yahoo Finance

Connect Biopharma Holdings Limited's (NASDAQ:CNTB) largest shareholders are private equity firms with 39% ownership, individual investors own 22%  Yahoo Finance

Connect Biopharma Holdings Limited's (NASDAQ:CNTB) largest shareholders are private equity firms with 39% ownership, individual investors own 22% - Yahoo Finance

Click here to get full coverage on Connect Biopharma (CNTB) Expected to Announce Earnings on Monday - MarketBeat

Connect Biopharma (CNTB) Expected to Announce Earnings on Monday  MarketBeat

Connect Biopharma (CNTB) Expected to Announce Earnings on Monday - MarketBeat

Click here to get full coverage on New asthma and COPD drug data arrive as Connect funds operations into 2027 - Stock Titan

New asthma and COPD drug data arrive as Connect funds operations into 2027  Stock Titan

New asthma and COPD drug data arrive as Connect funds operations into 2027 - Stock Titan

Click here to get full coverage on Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts  MarketBeat

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Click here to get full coverage on Connect Biopharma raises $20.2M, extends cash runway into 2027 - Stock Titan

Connect Biopharma raises $20.2M, extends cash runway into 2027  Stock Titan

Connect Biopharma raises $20.2M, extends cash runway into 2027 - Stock Titan

Click here to get full coverage on Entity tied to CNTB director James Huang buys 1.16M shares in open market - Stock Titan

Entity tied to CNTB director James Huang buys 1.16M shares in open market  Stock Titan

Entity tied to CNTB director James Huang buys 1.16M shares in open market - Stock Titan

Click here to get full coverage on Connect Biopharma (NASDAQ:CNTB) Receives "Buy" Rating from BTIG Research - MarketBeat

Connect Biopharma (NASDAQ:CNTB) Receives "Buy" Rating from BTIG Research  MarketBeat

Connect Biopharma (NASDAQ:CNTB) Receives "Buy" Rating from BTIG Research - MarketBeat

Click here to get full coverage on [Form 4] Connect Biopharma Holdings Ltd Insider Trading Activity - Stock Titan

[Form 4] Connect Biopharma Holdings Ltd Insider Trading Activity  Stock Titan

[Form 4] Connect Biopharma Holdings Ltd Insider Trading Activity - Stock Titan

Click here to get full coverage on Director at Connect Biopharma (CNTB) takes shares instead of cash pay - Stock Titan

Director at Connect Biopharma (CNTB) takes shares instead of cash pay  Stock Titan

Director at Connect Biopharma (CNTB) takes shares instead of cash pay - Stock Titan

Click here to get full coverage on Connect Biopharma (NASDAQ: CNTB) holder Panacea adds 1.16M shares - Stock Titan

Connect Biopharma (NASDAQ: CNTB) holder Panacea adds 1.16M shares  Stock Titan

Connect Biopharma (NASDAQ: CNTB) holder Panacea adds 1.16M shares - Stock Titan

Click here to get full coverage on [8-K] Connect Biopharma Holdings Ltd Reports Material Event - Stock Titan

[8-K] Connect Biopharma Holdings Ltd Reports Material Event  Stock Titan

[8-K] Connect Biopharma Holdings Ltd Reports Material Event - Stock Titan

Click here to get full coverage on Experimental asthma and COPD drug targets rapid relief during attacks - Stock Titan

Experimental asthma and COPD drug targets rapid relief during attacks  Stock Titan

Experimental asthma and COPD drug targets rapid relief during attacks - Stock Titan

Click here to get full coverage on An eczema drug kept nearly 9 in 10 patients almost clear at one year - Stock Titan

An eczema drug kept nearly 9 in 10 patients almost clear at one year  Stock Titan

An eczema drug kept nearly 9 in 10 patients almost clear at one year - Stock Titan

Click here to get full coverage on Connect Biopharma (CNTB) director linked fund reports 12M-share holding - Stock Titan

Connect Biopharma (CNTB) director linked fund reports 12M-share holding  Stock Titan

Connect Biopharma (CNTB) director linked fund reports 12M-share holding - Stock Titan

Click here to get full coverage on A 2-minute IV shot improved breathing fast in asthma and COPD - Stock Titan

A 2-minute IV shot improved breathing fast in asthma and COPD  Stock Titan

A 2-minute IV shot improved breathing fast in asthma and COPD - Stock Titan

Click here to get full coverage on [Form 3] Connect Biopharma Holdings Ltd Initial Statement of Beneficial Ownership - Stock Titan

[Form 3] Connect Biopharma Holdings Ltd Initial Statement of Beneficial Ownership  Stock Titan

[Form 3] Connect Biopharma Holdings Ltd Initial Statement of Beneficial Ownership - Stock Titan

Click here to get full coverage on Connect Biopharma (NASDAQ:CNTB) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat

Connect Biopharma (NASDAQ:CNTB) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS  MarketBeat

Connect Biopharma (NASDAQ:CNTB) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat

Click here to get full coverage on Severe eczema drug from Connect Biopharma lands late-breaking AAD slot - Stock Titan

Severe eczema drug from Connect Biopharma lands late-breaking AAD slot  Stock Titan

Severe eczema drug from Connect Biopharma lands late-breaking AAD slot - Stock Titan

Click here to get full coverage on Should I buy Connect Biopharma Holdings (CNTB) - Zacks Investment Research

Should I buy Connect Biopharma Holdings (CNTB)  Zacks Investment Research

Should I buy Connect Biopharma Holdings (CNTB) - Zacks Investment Research

Click here to get full coverage on Connect Biopharma (CNTB) CEO details stock option and share holdings - Stock Titan

Connect Biopharma (CNTB) CEO details stock option and share holdings  Stock Titan

Connect Biopharma (CNTB) CEO details stock option and share holdings - Stock Titan

Click here to get full coverage on Connect Biopharma (NASDAQ: CNTB) director reports initial share and option holdings - Stock Titan

Connect Biopharma (NASDAQ: CNTB) director reports initial share and option holdings  Stock Titan

Connect Biopharma (NASDAQ: CNTB) director reports initial share and option holdings - Stock Titan

Click here to get full coverage on CNTB Surges 13% — But Is This a Breakout or a Bounce? - Bitget

CNTB Surges 13% — But Is This a Breakout or a Bounce?  Bitget

CNTB Surges 13% — But Is This a Breakout or a Bounce? - Bitget

Click here to get full coverage on UL Monroe 81-31 Central Baptist (15 Nov, 2025) Final Score - espn.in

UL Monroe 81-31 Central Baptist (15 Nov, 2025) Final Score  espn.in

UL Monroe 81-31 Central Baptist (15 Nov, 2025) Final Score - espn.in

Click here to get full coverage on Connect Biopharma (CNTB) president discloses share and option holdings - Stock Titan

Connect Biopharma (CNTB) president discloses share and option holdings  Stock Titan

Connect Biopharma (CNTB) president discloses share and option holdings - Stock Titan

Click here to get full coverage on Connect Biopharma Announces $20.2 Million Private Placement Financing - ChartMill

Connect Biopharma Announces $20.2 Million Private Placement Financing  ChartMill

Connect Biopharma Announces $20.2 Million Private Placement Financing - ChartMill

Click here to get full coverage on Buy Rating on CNTB Driven by Rademikibart’s Rapid Lung Function Gains, COPD Differentiation, and Strengthened Cash Runway - TipRanks

Buy Rating on CNTB Driven by Rademikibart’s Rapid Lung Function Gains, COPD Differentiation, and Strengthened Cash Runway  TipRanks

Buy Rating on CNTB Driven by Rademikibart’s Rapid Lung Function Gains, COPD Differentiation, and Strengthened Cash Runway - TipRanks

Click here to get full coverage on Buy Rating on CNTB: Fast-Acting Rademikibart Data Underscore Differentiation and Long-Term Respiratory Opportunity - TipRanks

Buy Rating on CNTB: Fast-Acting Rademikibart Data Underscore Differentiation and Long-Term Respiratory Opportunity  TipRanks

Buy Rating on CNTB: Fast-Acting Rademikibart Data Underscore Differentiation and Long-Term Respiratory Opportunity - TipRanks

Click here to get full coverage on Connect Biopharma Raises $20.2 Million in Private Placement of 6.13 Million Shares at $3.25 - TradingView

Connect Biopharma Raises $20.2 Million in Private Placement of 6.13 Million Shares at $3.25  TradingView

Connect Biopharma Raises $20.2 Million in Private Placement of 6.13 Million Shares at $3.25 - TradingView

Click here to get full coverage on Connect Biopharma Announces $20.2 Million Private Placement Financing - GlobeNewswire

Connect Biopharma Announces $20.2 Million Private Placement Financing  GlobeNewswire

Connect Biopharma Announces $20.2 Million Private Placement Financing - GlobeNewswire

Click here to get full coverage on Connect Biopharma Announces Positive Topline Data from its - GlobeNewswire

Connect Biopharma Announces Positive Topline Data from its  GlobeNewswire

Connect Biopharma Announces Positive Topline Data from its - GlobeNewswire

Click here to get full coverage on Connect Biopharma Holdings Ltd reports results for the quarter ended December 31 - Earnings Summary - TradingView

Connect Biopharma Holdings Ltd reports results for the quarter ended December 31 - Earnings Summary  TradingView

Connect Biopharma Holdings Ltd reports results for the quarter ended December 31 - Earnings Summary - TradingView

Click here to get full coverage on Connect Biopharma Drops 20.7% During the Day—Market Shaken by Sudden Reversal - Bitget

Connect Biopharma Drops 20.7% During the Day—Market Shaken by Sudden Reversal  Bitget

Connect Biopharma Drops 20.7% During the Day—Market Shaken by Sudden Reversal - Bitget

Click here to get full coverage on Louisiana Tech 97-24 Central Baptist (Dec 20, 2025) Final Score - ESPN

Louisiana Tech 97-24 Central Baptist (Dec 20, 2025) Final Score  ESPN

Louisiana Tech 97-24 Central Baptist (Dec 20, 2025) Final Score - ESPN

Click here to get full coverage on Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study - GlobeNewswire

Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study  GlobeNewswire

Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study - GlobeNewswire

Click here to get full coverage on CNTB Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

CNTB Stock News Today | Earnings, Events & Price Alerts  Intellectia AI

CNTB Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Click here to get full coverage on Connect Biopharma Announces Positive Topline Data From Its Phase 1 Study Of Intravenous (Iv) Rademikibart In Patients With Asthma Or Copd - TradingView

Connect Biopharma Announces Positive Topline Data From Its Phase 1 Study Of Intravenous (Iv) Rademikibart In Patients With Asthma Or Copd  TradingView

Connect Biopharma Announces Positive Topline Data From Its Phase 1 Study Of Intravenous (Iv) Rademikibart In Patients With Asthma Or Copd - TradingView

Click here to get full coverage on 3 Promising Penny Stocks With Market Caps Up To $400M - simplywall.st

3 Promising Penny Stocks With Market Caps Up To $400M  simplywall.st

3 Promising Penny Stocks With Market Caps Up To $400M - simplywall.st

Click here to get full coverage on Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - GlobeNewswire

Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference  GlobeNewswire

Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - GlobeNewswire

Click here to get full coverage on Connect Biopharma raises $20.2 million in private placement - Investing.com

Connect Biopharma raises $20.2 million in private placement  Investing.com

Connect Biopharma raises $20.2 million in private placement - Investing.com

Click here to get full coverage on Connect Biopharma Highlights Positive Rademikibart Respiratory Trial Results - TipRanks

Connect Biopharma Highlights Positive Rademikibart Respiratory Trial Results  TipRanks

Connect Biopharma Highlights Positive Rademikibart Respiratory Trial Results - TipRanks

Click here to get full coverage on Connect Biopharma (CNTB) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat

Connect Biopharma (CNTB) FDA Approvals, PDUFA Dates & Drug Alerts 2026  MarketBeat

Connect Biopharma (CNTB) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat

Click here to get full coverage on Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting - GlobeNewswire

Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting  GlobeNewswire

Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting - GlobeNewswire

Click here to get full coverage on Simcere’s rademikibart AD study selected for AAD presentation - Investing.com

Simcere’s rademikibart AD study selected for AAD presentation  Investing.com

Simcere’s rademikibart AD study selected for AAD presentation - Investing.com

Click here to get full coverage on Connect Biopharma Completes Termination of its American - GlobeNewswire

Connect Biopharma Completes Termination of its American  GlobeNewswire

Connect Biopharma Completes Termination of its American - GlobeNewswire

Click here to get full coverage on BTIG reiterates Buy on Connect Biopharma stock after Phase 1 data By Investing.com - Investing.com South Africa

BTIG reiterates Buy on Connect Biopharma stock after Phase 1 data By Investing.com  Investing.com South Africa

BTIG reiterates Buy on Connect Biopharma stock after Phase 1 data By Investing.com - Investing.com South Africa

Click here to get full coverage on Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Milwaukee Journal Sentinel

Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV  Milwaukee Journal Sentinel

Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Milwaukee Journal Sentinel

Click here to get full coverage on Major Insider Move Signals Strong Confidence in Connect Biopharma’s Future - TipRanks

Major Insider Move Signals Strong Confidence in Connect Biopharma’s Future  TipRanks

Major Insider Move Signals Strong Confidence in Connect Biopharma’s Future - TipRanks

Click here to get full coverage on Connect Biopharma raises $20.2 million in private placement By Investing.com - Investing.com South Africa

Connect Biopharma raises $20.2 million in private placement By Investing.com  Investing.com South Africa

Connect Biopharma raises $20.2 million in private placement By Investing.com - Investing.com South Africa

Click here to get full coverage on Connect Biopharma raises $20.2 million in private placement By Investing.com - Investing.com Australia

Connect Biopharma raises $20.2 million in private placement By Investing.com  Investing.com Australia

Connect Biopharma raises $20.2 million in private placement By Investing.com - Investing.com Australia

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Connect Biopharma stock jumps on positive drug trial results By Investing.com - Investing.com India

Connect Biopharma stock jumps on positive drug trial results By Investing.com  Investing.com India

Connect Biopharma stock jumps on positive drug trial results By Investing.com - Investing.com India

Click here to get full coverage on Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference - GlobeNewswire

Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference  GlobeNewswire

Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference - GlobeNewswire

Click here to get full coverage on Connect Biopharma stock jumps on positive drug trial results By Investing.com - Investing.com UK

Connect Biopharma stock jumps on positive drug trial results By Investing.com  Investing.com UK

Connect Biopharma stock jumps on positive drug trial results By Investing.com - Investing.com UK

Click here to get full coverage on Latest CNTB News - Connect Biopharma Reports 2025 Full-Year Fi... - Stock Titan

Latest CNTB News - Connect Biopharma Reports 2025 Full-Year Fi...  Stock Titan

Latest CNTB News - Connect Biopharma Reports 2025 Full-Year Fi... - Stock Titan

Click here to get full coverage on Connect Biopharma Holdings Limited's (NASDAQ:CNTB) top owners are private equity firms with 39% stake, while 22% is held by insiders - Yahoo Finance

Connect Biopharma Holdings Limited's (NASDAQ:CNTB) top owners are private equity firms with 39% stake, while 22% is held by insiders  Yahoo Finance

Connect Biopharma Holdings Limited's (NASDAQ:CNTB) top owners are private equity firms with 39% stake, while 22% is held by insiders - Yahoo Finance

Click here to get full coverage on CNTB Stock Price and Chart — NASDAQ:CNTB - TradingView

CNTB Stock Price and Chart — NASDAQ:CNTB  TradingView

CNTB Stock Price and Chart — NASDAQ:CNTB - TradingView

Click here to get full coverage on What Kind Of Investors Own Most Of Connect Biopharma Holdings Limited (NASDAQ:CNTB)? - Yahoo Finance

What Kind Of Investors Own Most Of Connect Biopharma Holdings Limited (NASDAQ:CNTB)?  Yahoo Finance

What Kind Of Investors Own Most Of Connect Biopharma Holdings Limited (NASDAQ:CNTB)? - Yahoo Finance

Click here to get full coverage on Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update - Stock Titan

Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update  Stock Titan

Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update - Stock Titan

Click here to get full coverage on ‘Croatia Full of Life’ completes first successful workshop event - Travelweek

‘Croatia Full of Life’ completes first successful workshop event  Travelweek

‘Croatia Full of Life’ completes first successful workshop event - Travelweek

Click here to get full coverage on What is the current Price Target and Forecast for Connect Biopharma Holdings (CNTB) - Zacks Investment Research

What is the current Price Target and Forecast for Connect Biopharma Holdings (CNTB)  Zacks Investment Research

What is the current Price Target and Forecast for Connect Biopharma Holdings (CNTB) - Zacks Investment Research

Click here to get full coverage on Connect Biopharma Holdings American Depositary Shares Stock Price Forecast. Should You Buy CNTB? - StockInvest.us

Connect Biopharma Holdings American Depositary Shares Stock Price Forecast. Should You Buy CNTB?  StockInvest.us

Connect Biopharma Holdings American Depositary Shares Stock Price Forecast. Should You Buy CNTB? - StockInvest.us

Click here to get full coverage on CNTB Stock Price, Quote & Chart | CONNECT BIOPHARMA HOLDINGS L (NASDAQ:CNTB) - ChartMill

CNTB Stock Price, Quote & Chart | CONNECT BIOPHARMA HOLDINGS L (NASDAQ:CNTB)  ChartMill

CNTB Stock Price, Quote & Chart | CONNECT BIOPHARMA HOLDINGS L (NASDAQ:CNTB) - ChartMill

Click here to get full coverage on Connect Biopharma (CNTB) Stock Price, News & Analysis - MarketBeat

Connect Biopharma (CNTB) Stock Price, News & Analysis  MarketBeat

CNTB

Price Chart

Key Statistics

Technicals

About CNTB

Latest News

Q1 Earnings Estimate for CNTB Issued By HC Wainwright - MarketBeat

If You Invested $1,000 in Connect Biopharma Holdings Ltd (CNTB) - Stock Titan

H.C. Wainwright Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $7 - 富途牛牛

Advanced Charts

Top Gainers

Top Losers